Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study (Q84270711)
Jump to navigation
Jump to search
scientific article published on 21 July 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study |
scientific article published on 21 July 2009 |
Statements
Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study (English)
P Quaglino
F Marenco
S Osella-Abate
N Cappello
M Ortoncelli
B Salomone
M T Fierro
P Savoia